マイクロコンピューター断層撮影（CT）の世界市場：2024-2031年

マイクロコンピューター断層撮影（CT）の世界市場規模、シェア、動向分析レポート：製品別（生体内、生体外）、用途別（生命科学、骨、歯科、植物・食品、材料科学、地質・石油・ガス地質）、エンドユーザー別（病院・クリニック、診断研究所、学術・研究機関、製薬・バイオテクノロジー企業）予測期間（2024-2031年）

世界のマイクロCT市場は予測期間（2024-2031年）にCAGR7.2％で成長すると予測されます。同市場の成長は、特に手術計画、医療機器製造、組織工学など、ヘルスケアにおける3Dプリンティングの利用拡大により、マイクロCTのような高品質な3D画像モダリティに対するニーズが高まっていることに起因しています。国立衛生研究所によると、2023年9月、世界全体では、命を救い障害を予防するために、低・中所得国で毎年1億4,300万件の追加外科手術が必要とされていますが、3Dプリンティングによる臓器モデルの製造におけるAIの応用は、高品質で高スループットのモデルの実現に関連する課題を浮き彫りにしています。AIとML技術の積層造形（AM）への統合は、複雑な情報処理を自動化し、合理的な意思決定を支援し、最終的には術前シミュレーションのための臓器モデルの開発を強化する可能性を秘めています。しかし、臨床処置に3Dプリンティングと組み合わせたAIの使用に関する調査は現在限られており、このプロセスの精度と効率を最適化するにはさらなる進歩が必要です。

市場力学

高解像度イメージングの普及拡大

マイクロCTは高解像度イメージングを提供し、正確な診断とがんの早期発見を可能にします。特定の腫瘍の特徴を可視化することで、医師が目標を定め、行動計画を立てるのに役立ちます。2023年1月の国立衛生研究所によると、がんは世界で最も重大な死亡原因であり、2020年には世界で1,000万人が死亡し、1,930万人が新たに診断されました。陽電子放射断層撮影法（PET）、コンピュータ断層撮影法（CT）、磁気共鳴分光法（MRS）、分子診断法などの診断ツールの使用により、早期発見率と治療管理は改善されてきました。とはいえ、深部悪性腫瘍を正確に診断するためには、優れた標的定義と高額な費用が障害となっています。特に低・中所得国におけるがん治療を改善するため、本研究では画像診断、分子診断、安価な診断技術を検討します。

ヘルスケア用途の増加

高解像度イメージングシステムは、前臨床研究、歯列矯正研究、歯科イメージングなど、ヘルスケアにおけるマイクロCTの利用が進むにつれて、ますます需要が高まると予想されます。例えば、2023年5月、Nikon Metrologyは、様々な産業分野の検査・分析用に設計された大容量CTシステム、VOXLS 40 C 450を発表しました。花崗岩ベースのマニピュレーター、高剛性スチールタワー、モーター、エンコーダー、2つのマイクロフォーカスX線源が特徴です。

市場セグメンテーション

世界のマイクロCT（コンピューター断層撮影）市場を詳細に分析すると、製品、用途、エンドユーザー別に以下のように区分される：

• 製品別では、市場は生体内と生体外に細分化されます。
• 用途別では、ライフサイエンス、骨、歯科、植物・食品、材料科学、地質学・石油・ガス地質に細分化されます。
• エンドユーザーに基づくと、市場は病院・診療所、診断研究所、学術・研究機関、製薬・バイオテクノロジー企業に二分されます。

生体外が最大セグメントとなる見込み

生体外サブセグメントは、高解像度の3D可視化に対する需要の増加により、市場で最大のシェアを占めると予想されています。2022年9月に発表された国立衛生研究所（NIH.gov）の調査によると、光干渉断層計（OCT）や超音波検査などの他の画像モダリティと比較して、マイクロCTは3D画像においてより高い空間分解能と精度を提供し、眼組織や疾患の詳細な特徴付けを可能にします。臨床における眼球解剖学的構造の生体外イメージングには、通常、光干渉断層計（OCT）、磁気共鳴画像法（MRI）、眼球超音波検査法、または蛍光ベースの検眼鏡検査法が使用されます。これらの方法は迅速かつ広範な調査を可能にしますが、解像度は250マイクロメートル、深さは10マイクロメートルにとどまりました。したがって、マイクロCTは、高分解能イメージングと3D可視化を時間通りに組み合わせるのに好ましい方法です。しかし、未処理の軟部組織の放射線強度が低いことや、X線の部分的な減衰が課題です。

市場セグメンテーションでは、診断検査部門が大きなシェアを占める

マイクロCTシステムは、商業および学術の両領域において、材料科学、冶金学、地質学に不可欠です。このシステムは、さまざまな産業における故障解析、プロセス最適化、品質管理、材料特性評価を改善します。例えば、2021年3月、Zeiss Research Microscopy Solutionsは、Xradia CrystalCTマイクロCTシステムを発表しました。このシステムは、産業および学術研究所の様々な用途向けに多結晶材料の3D結晶イメージングを可能にします。

地域別展望

世界のマイクロCT（コンピュータ断層撮影）市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋（インド、中国、日本、韓国、その他アジア地域）、その他世界の地域（中東・アフリカ、ラテンアメリカ）を含む地域別にさらに細分化されます。

アジア太平洋におけるバイオテクノロジー産業の爆発的成長

• 遺伝子工学、バイオプロセス、バイオインフォマティクスが牽引するインドのバイオテクノロジー産業の急成長により、マイクロCTのような高度なイメージング技術は、高解像度で精密なバイオテクノロジー研究に不可欠です。
• インド・ブランド・エクイティ財団（IBEF）によると、2024年2月、インドのバイオエコノミー産業は2015年の100億米ドルから2023年には800億米ドルへと大きく成長し、同国のGDPに2.6％寄与しています。COVID-19のワクチン接種と検査の推進は、業界のほぼ5分の1に相当する146億米ドルに貢献しています。バイオファーマはバイオ経済の49％を占め、最大の貢献は3,940億米ドルと推定されます。インドのバイオテクノロジー産業は、2015年から2020年の間に302億米ドルから702億米ドルに倍増し、2025年には1,500億米ドルに達し、2030年には2,700億米ドルから3,000億米ドルに達すると予想されています。

北米が主要市場シェアを占める

高齢化、難治性疾患の増加、画像誘導治療への医療変化、技術開発が市場を牽引しています。

さらに、2022年5月の国立衛生研究所によると、骨折のリスクを高める慢性的な骨代謝状態は、骨粗鬆症や低骨量を含む低骨密度（LBMD）です。米国では1,000万人以上が罹患しており、2020年までに50歳以上の1,400万人が罹患すると予測されています。最も深刻な結果は骨折であり、2050年までに股関節骨折の発生率が240％と310％増加すると予測されています。LBMD患者は骨折を経験する可能性が高く、脆弱性骨折が最も一般的です。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Bruker Corp.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Carl Zeiss AG
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• GE HealthCare Technologies Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• マイクロコンピューター断層撮影（CT）の世界市場：製品別
  • 生体内
  • 生体外
• マイクロコンピューター断層撮影（CT）の世界市場：用途別
  • ライフサイエンス
  • 骨
  • 歯科
  • 植物・食品
  • 材料科学
  • 地質学/石油・ガス地質学
• マイクロコンピューター断層撮影（CT）の世界市場：エンドユーザー別
  • 病院・診療所
  • 診断研究所
  • 学術・研究機関
  • 製薬・バイオテクノロジー企業

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 世界のその他の地域

第6章 企業プロファイル

• Animage, LLC
• Aspect Imaging Ltd.
• Comet Yxlon GmbH
• Hitachi, Ltd.
• Mediso Kft.
• MILabs B.V.
• Nikon India Pvt. Ltd.
• PerkinElmer AES
• Rigaku Holdings Corp.
• SCANCO Medical AG
• Siemens Healthineers Co.
• TESCAN GROU
• Thermo Fisher Scientific Inc.

LIST OF TABLES

• 1.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 2.GLOBAL IN-VIVO MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 3.GLOBAL EX-VIVO MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 4.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
• 5.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN LIFE SCIENCES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 6.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN BONES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 7.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN DENTISTRY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 8.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN PLANTS AND FOOD MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 9.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN MATERIAL SCIENCE MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 10.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN GEOLOGY/OIL AND GAS GEOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 11.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 12.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) FOR HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 13.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) FOR DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 14.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) FOR ACADEMIC AND RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 15.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 16.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 17.NORTH AMERICAN MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 18.NORTH AMERICAN MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 19.NORTH AMERICAN MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
• 20.NORTH AMERICAN MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 21.EUROPEAN MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 22.EUROPEAN MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 23.EUROPEAN MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
• 24.EUROPEAN MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 25.ASIA-PACIFIC MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 26.ASIA-PACIFIC MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 27.ASIA-PACIFIC MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
• 28.ASIA-PACIFIC MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 29.REST OF THE WORLD MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 30.REST OF THE WORLD MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 31.REST OF THE WORLD MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
• 32.REST OF THE WORLD MICRO-COMPUTED TOMOGRAPHY (CT) MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)

LIST OF FIGURES

• 1.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY PRODUCT, 2023 VS 2031 (%)
• 2.GLOBAL IN-VIVO MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 3.GLOBAL EX-VIVO MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 4.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY APPLICATION, 2023 VS 2031 (%)
• 5.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN LIFE SCIENCES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 6.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN BONES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 7.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN DENTISTRY MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 8.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN PLANTS AND FOOD MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 9.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN MATERIAL SCIENCE MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 10.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) IN GEOLOGY/OIL AND GAS GEOLOGY MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 11.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY END-USER, 2023 VS 2031 (%)
• 12.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) FOR HOSPITALS AND CLINICS MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 13.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) FOR DIAGNOSTIC LABORATORIES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 14.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) FOR ACADEMIC AND RESEARCH INSTITUTIONS MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 15.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 16.GLOBAL MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 17.US MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 18.CANADA MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 19.UK MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 20.FRANCE MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 21.GERMANY MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 22.ITALY MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 23.SPAIN MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 24.REST OF EUROPE MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 25.INDIA MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 26.CHINA MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 27.JAPAN MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 28.SOUTH KOREA MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 29.REST OF ASIA-PACIFIC MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 30.LATIN AMERICA MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)
• 31.THE MIDDLE EAST AND AFRICA MICRO-COMPUTED TOMOGRAPHY (CT) MARKET SIZE, 2023-2031 ($ MILLION)

Global Micro-Computed Tomography (CT) Market Size, Share & Trends Analysis Report by Product (In-Vivo and Ex-Vivo), by Application (Life Sciences, Bones, Dentistry, Plants and Food, Material Science, and Geology/Oil and Gas Geology), and by End-User (Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutions, and Pharmaceutical and Biotechnology Companies) Forecast Period (2024-2031)

Global micro-CT market is anticipated to grow at a CAGR of 7.2% during the forecast period (2024-2031). The market's growth is attributed to the need for high-quality 3D imaging modalities like micro-CT is increasing owing to the expanding usage of 3D printing in healthcare, particularly in surgery planning, medical device production, and tissue engineering. According to the National Institute of Health (gov.), in September 2023, globally, 143 million additional surgical procedures are needed each year in low- and middle-income countries to save lives and prevent disability however, the application of AI in the production of organs models through 3D printing and highlights the challenges associated with achieving high-quality, high-throughput models. The integration of AI and ML technology into additive manufacturing (AM) has the potential to automate complex information processing and assist in making rational decisions, ultimately enhancing the development of organ models for preoperative simulations. However, there is currently limited research on the use of AI combined with 3D printing for clinical procedures, and further advancements are needed to optimize the accuracy and efficiency of this process.

Market Dynamics

Growing Prevalence of High-Resolution Imaging

Micro-CT offers high-resolution imaging for precise diagnosis and early cancer detection. By visualizing specific tumor characteristics, it helps physicians define their goals and plan the course of action. According to the National Institute of Health, (gov.) in January 2023, Cancer is the globe's most significant cause of mortality, accounting for 10. million deaths and 19.3 million new diagnoses globally in 2020. Early detection rates and therapeutic management have improved with the use of diagnostic tools such as positron emission tomography (PET), computed tomography (CT), magnetic resonance spectroscopy (MRS), and molecular diagnostics. Nevertheless, obstacles include superior target definition and high expense rendering it complicated to diagnose deep-seated malignancies accurately. To improve cancer care, especially in low- and middle-income nations, to examine imaging, molecular, and inexpensive diagnostic technologies in this study.

Increasing the Use of Healthcare Applications

High-resolution imaging systems are expected to grow more and more in demand as micro-CT is used progressively in healthcare for preclinical research, orthodontic studies, and dental imaging. For instance, in May 2023, Nikon Metrology introduced the VOXLS 40 C 450, a large-volume CT system designed for inspection and analysis across various industries. It featured a granite-based manipulator, rigid steel towers, motors, and encoders, and two microfocus X-ray sources.

Market Segmentation

Our in-depth analysis of the global Micro Computed Tomography market includes the following segments by product, application, and end-user:

• Based on product, the market is sub-segmented into in-vivo, and ex-vivo.
• Based on application, the market is sub-segmented into life sciences, bones, dentistry, plants and food, material science, and geology/oil and gas geology.
• Based on end-users, the market is bifurcated into hospitals and clinics, diagnostic laboratories, academic and research institutions, and pharmaceutical and biotechnology companies.

Ex-Vivo is Projected to Emerge as the Largest Segment

The ex-vivo sub-segment is expected to hold the largest share of the market owing to the increasing demand for high-resolution 3D visualization. According to the National Institute of Health (NIH.gov) survey published in September 2022, compared to other imaging modalities such as optical coherence tomography (OCT) and ultrasonography, micro-CT offers higher spatial resolution and precision in 3D imaging, enabling detailed characterization of ocular tissues and disease. Clinical ex-vivo imaging of ocular anatomy typically uses optical coherence tomography (OCT), magnetic resonance imaging (MRI), ocular ultrasonography, or fluorescence-based ophthalmoscopy. These methods offer fast and extensive investigations, though can reach resolutions down to 250 µm and 10 µm in depth. Hence, micro-CT is the preferred method for combining high-resolution imaging with 3D visualization on time. However, challenges include low radiodensity of untreated soft tissues and partial X-ray attenuation.

Diagnostic Laboratories Sub-segment to Hold a Considerable Market Share

The micro-CT systems are essential for materials science, metallurgy, and geology in both the commercial and academic domains. It improves failure analysis, process optimization, quality control, and materials characterization across a range of industries. For instance, in March 2021, Zeiss Research Microscopy Solutions introduced the Xradia CrystalCT micro-CT system, which enables 3D crystallographic imaging of polycrystalline materials for various applications in industrial and academic laboratories.

Regional Outlook

The global micro-computed tomography (CT) market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).

Explosive Growth of Biotechnology Industry in Asia-Pacific Region

• Advanced imaging technologies such as micro-CT are essential for high-resolution, precise biotechnological research owing to the biotechnology industry's rapid growth in India, which is driven by genetic engineering, bioprocessing, and bioinformatics.
• According to the India Brand Equity Foundation (IBEF ), in February 2024, India's bio-economy industry has grown significantly, from $10 billion in 2015 to $80 billion in 2023, contributing 2.6% to the country's GDP. The COVID-19 vaccination and testing drive has contributed nearly a 5th of the industry's worth, worth $14. 6 billion. Biopharma, accounting for 49% of the bio-economy, contributes the largest portion, estimated at $394 billion. The Indian biotechnology industry, which doubled from $30.2 billion to $70.2 billion between 2015 and 2020, is expected to reach $150 billion by 2025 and reach $270-300 billion by 2030.

North America Holds Major Market Share

Among all the regions, North America holds a significant share owing to the growing demand for advanced imaging technologies such as micro-CT is driven by the increasing geriatric population.The aging population, an increasing number of persistent diseases, the change in medical treatment toward image-guided treatments, and technology developments have been driving the market.

Furthermore, according to the National Institute of Health (gov.) in May 2022, chronic bone metabolic condition that increases the risk of fractures is low bone mineral density (LBMD), which includes osteoporosis and low bone mass. In the US, it affects more than 10 million people, and by 2020, 14 million individuals over 50 are predicted to be impacted. The most serious consequence is fractures, with a predicted 240% and 310% increase in hip fracture incidence by 2050. Patients with LBMD are more likely to experience fractures, with fragility fractures being the most common type.

Market Players Outlook

The major companies serving the global micro computed tomography market include AggreDyne, Inc., Medtronic Pvt. Ltd., Siemens Healthineers Co., Sysmex Corp. Werfen, S.A., and others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in May 2023, Revvity launched three state-of-the-art imaging systems such as the Vega ultrasound system, the QuantumTM GX3 micro-CT structural imaging solution, and the IVIS Spectrum 2 and SpectrumCT 2. These innovations are expected to be on display in Prague at the World Molecular Imaging Congress.

The Report Covers:

• Market value data analysis of 2023 and forecast to 2031.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global micro-computed tomography (CT) market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1.Research Methods and Tools
• 1.2.Market Breakdown
  • 1.2.1.By Segments
  • 1.2.2.By Region

2.Market Overview and Insights

• 2.1.Scope of the Report
• 2.2.Analyst Insight & Current Market Trends
  • 2.2.1.Key Findings
  • 2.2.2.Recommendations
  • 2.2.3.Conclusion

3.Competitive Landscape

• 3.1.Key Company Analysis
• 3.2.Bruker Corp.
  • 3.2.1.Overview
  • 3.2.2.Financial Analysis
  • 3.2.3.SWOT Analysis
  • 3.2.4.Recent Developments
• 3.3.Carl Zeiss AG
  • 3.3.1.Overview
  • 3.3.2.Financial Analysis
  • 3.3.3.SWOT Analysis
  • 3.3.4.Recent Developments
• 3.4.GE HealthCare Technologies Inc.
  • 3.4.1.Overview
  • 3.4.2.Financial Analysis
  • 3.4.3.SWOT Analysis
  • 3.4.4.Recent Developments
• 3.5.Key Strategy Analysis

4.Market Segmentation

• 4.1.Global Micro-Computed Tomography (CT) Market by Product
  • 4.1.1.In-Vivo
  • 4.1.2.Ex-vivo
• 4.2.Global Micro-Computed Tomography (CT) Market by Application
  • 4.2.1.Life Sciences
  • 4.2.2.Bones
  • 4.2.3.Dentistry
  • 4.2.4.Plants and Food
  • 4.2.5.Material Science
  • 4.2.6.Geology/Oil and Gas Geology
• 4.3.Global Micro-Computed Tomography (CT) Market by End-User
  • 4.3.1.Hospitals and Clinics
  • 4.3.2.Diagnostic Laboratories
  • 4.3.3.Academic and Research Institutions
  • 4.3.4.Pharmaceutical and Biotechnology Companies

5.Regional Analysis

• 5.1.North America
  • 5.1.1.United States
  • 5.1.2.Canada
• 5.2.Europe
  • 5.2.1.UK
  • 5.2.2.Germany
  • 5.2.3.Italy
  • 5.2.4.Spain
  • 5.2.5.France
  • 5.2.6.Rest of Europe
• 5.3.Asia-Pacific
  • 5.3.1.China
  • 5.3.2.India
  • 5.3.3.Japan
  • 5.3.4.South Korea
  • 5.3.5.Rest of Asia-Pacific
• 5.4.Rest of the World

6.Company Profiles

• 6.1.Animage, LLC
• 6.2.Aspect Imaging Ltd.
• 6.3.Comet Yxlon GmbH
• 6.4.Hitachi, Ltd.
• 6.5.Mediso Kft.
• 6.6.MILabs B.V.
• 6.7.Nikon India Pvt. Ltd.
• 6.8.PerkinElmer AES
• 6.9.Rigaku Holdings Corp.
• 6.10.SCANCO Medical AG
• 6.11.Siemens Healthineers Co.
• 6.12.TESCAN GROU
• 6.13.Thermo Fisher Scientific Inc.